Colextran
Top View
- Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark∗
- Harmonized Tariff Schedule of the United States (2006) (Rev
- In Vitro and in Vivo Evaluation of Novel Cross-Linked Saccharide Based Polymers As Bile Acid Sequestrants
- Regulatory Change in Pharmaceutical Price: Evidence from A
- Trends in Lipid-Modifying Agent Use in 83 Countries
- Pharmaceutical Appendix to the Tariff Schedule 2
- [Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
- 'Essays in Regulation of Pharmaceutical Markets'
- Zbwleibniz-Informationszentrum
- Lipid Modification Cardiovascular Risk Assessment and the Modification of Blood Lipids for the Primary and Secondary Prevention of Cardiovascular Disease
- Pharmaceutical Appendix to the Tariff Schedule 2
- Regulation of Pharmaceutical Prices: Evidence from a Reference Price Reform in Denmark
- Non-Interventional Study Protocol
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- Arzneimittel Richtwertvereinbarung Nach § 106B Abs
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri